Asit Parikh - 02 Jun 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director
Signature
/s/ Larry Miller, Attorney-in-Fact for Asit Parikh
Issuer symbol
PHAT
Transactions as of
02 Jun 2023
Net transactions value
+$111,000
Form type
4
Filing time
05 Jun 2023, 18:37:49 UTC
Previous filing
30 May 2023
Next filing
08 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $111,000 +15,000 +46% $7.40 47,500 02 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Disposed to Issuer $0 -15,000 -100% $0.000000* 0 02 Jun 2023 Common Stock 15,000 $7.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program and vested/became exercisable on the first anniversary of the date of grant.